title: Can ErbB2 overexpression protect against doxorubicin cardiotoxicity?
authors: Department of Pharmacology, New York Medical College, Valhalla, New York petra_rocic@nymc.edu.
authors: Petra
authors: P
authors: Rocic
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity*; D000975:Antioxidants / Q000378:metabolism*; D004317:Doxorubicin / Q000633:toxicity*; D005979:Glutathione Peroxidase / Q000378:metabolism*; D006331:Heart Diseases / Q000517:prevention & control*; D008929:Mitochondria, Heart / Q000187:drug effects*; D032383:Myocytes, Cardiac / Q000187:drug effects*; D018384:Oxidative Stress / Q000187:drug effects*; D017382:Reactive Oxygen Species / Q000378:metabolism*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D000975:Antioxidants; D004317:Doxorubicin; D005979:Glutathione Peroxidase; D017382:Reactive Oxygen Species; D018719:Erb-b2 Receptor Tyrosine Kinases